232 related articles for article (PubMed ID: 33571561)
1. Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation network.
Fluschnik N; Geelhoed B; Becher PM; Schrage B; Brunner FJ; Knappe D; Bernhardt AM; Blankenberg S; Kobashigawa J; Reichenspurner H; Schnabel RB; Magnussen C
Int J Cardiol; 2021 May; 331():57-62. PubMed ID: 33571561
[TBL] [Abstract][Full Text] [Related]
2. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients.
Kobayashi D; Du W; L'ecuyer TJ
Pediatr Transplant; 2013 Aug; 17(5):436-40. PubMed ID: 23714284
[TBL] [Abstract][Full Text] [Related]
3. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
[TBL] [Abstract][Full Text] [Related]
4. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation.
Sánchez Lázaro IJ; Almenar Bonet L; Moro López J; Sánchez Lacuesta E; Martínez-Dolz L; Agüero Ramón-Llín J; Andrés Lalaguna L; Cano Pérez O; Ortiz Martínez V; Buendía Fuentes F; Salvador Sanz A
Transplant Proc; 2008 Nov; 40(9):3056-7. PubMed ID: 19010192
[TBL] [Abstract][Full Text] [Related]
5. Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation.
Nagji AS; Hranjec T; Swenson BR; Kern JA; Bergin JD; Jones DR; Kron IL; Lau CL; Ailawadi G
Ann Thorac Surg; 2010 Jul; 90(1):168-75. PubMed ID: 20609769
[TBL] [Abstract][Full Text] [Related]
6. Cardiac allograft vasculopathy in pediatric heart transplant recipients does early-onset portend a worse prognosis?
Khoury M; Conway J; Gossett JG; Edens E; Soto S; Cantor R; Koehl D; Barnes A; Exil V; Glass L; Kirklin JK; Zuckerman WA
J Heart Lung Transplant; 2022 May; 41(5):578-588. PubMed ID: 35172937
[TBL] [Abstract][Full Text] [Related]
7. Epicardial fat volume is related to the degree of cardiac allograft vasculopathy.
Roest S; Budde RPJ; Brugts JJ; von der Thüsen J; van Walsum T; Taverne YJHJ; Zijlstra F; Bos D; Manintveld OC
Eur Radiol; 2023 Jan; 33(1):330-338. PubMed ID: 35986769
[TBL] [Abstract][Full Text] [Related]
8. Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry.
Khush KK; Kubo JT; Desai M
J Heart Lung Transplant; 2012 May; 31(5):459-66. PubMed ID: 22418079
[TBL] [Abstract][Full Text] [Related]
9. Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors.
Kadosh BS; Birs AS; Flattery E; Stachel M; Hong KN; Xia Y; Gidea C; Aslam S; Razzouk L; Saraon T; Goldberg R; Rao S; Pretorius V; Moazami N; Smith DE; Adler ED; Reyentovich A
Clin Transplant; 2024 Apr; 38(4):e15294. PubMed ID: 38545881
[TBL] [Abstract][Full Text] [Related]
10. Prediction model for cardiac allograft vasculopathy: Comparison of three multivariable methods.
Kransdorf EP; Loghmanpour NA; Kanwar MK; Temkit MH; Stehlik J
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28181298
[TBL] [Abstract][Full Text] [Related]
11. Heart Transplantation and Risk of Cardiac Vasculopathy Development: What Factors Are Important?
Sobieszczańska-Małek M; Korewicki J; Komuda K; Karczmarz M; Szymańska S; Cicha-Mikołajczyk A; Bekta P; Parulski A; Pronicki M; Grajkowska W; Małek G; Leszek P; Kaczorowska M; Kuśmierczyk M; Zieliński T
Ann Transplant; 2017 Nov; 22():682-688. PubMed ID: 29146891
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
[TBL] [Abstract][Full Text] [Related]
13. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
Amancherla K; Feurer ID; Rega SA; Cluckey A; Salih M; Davis J; Pedrotty D; Ooi H; Rali AS; Siddiqi HK; Menachem J; Brinkley DM; Punnoose L; Sacks SB; Zalawadiya SK; Wigger M; Balsara K; Trahanas J; McMaster WG; Hoffman J; Pasrija C; Lindenfeld J; Shah AS; Schlendorf KH
J Card Fail; 2024 May; 30(5):694-700. PubMed ID: 37907147
[TBL] [Abstract][Full Text] [Related]
14. Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis.
D'Addese L; Cantor RS; Koehl D; Reardon L; Ameduri R; Bock M; Morrison A; White S; Wisotzkey B; Kirklin JK; Godown J
J Heart Lung Transplant; 2023 Jan; 42(1):115-123. PubMed ID: 36328858
[TBL] [Abstract][Full Text] [Related]
15. Interaction of older donor age and survival after weight-matched pediatric heart transplantation.
Westbrook TC; Morales DLS; Khan MS; Bryant R; Castleberry C; Chin C; Zafar F
J Heart Lung Transplant; 2017 May; 36(5):554-558. PubMed ID: 28073609
[TBL] [Abstract][Full Text] [Related]
16. Survival, graft function, and incidence of allograft vasculopathy in heart transplant patients receiving adverse risk profile donor hearts.
Berg K; Clemmensen TS; Tram EM; Koefoed-Nielsen P; Ilkjaer LB; Poulsen SH; Eiskjaer H
Clin Transplant; 2018 Aug; 32(8):e13343. PubMed ID: 29974979
[TBL] [Abstract][Full Text] [Related]
17. Predicting the development of cardiac allograft vasculopathy.
Seki A; Fishbein MC
Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
[TBL] [Abstract][Full Text] [Related]
18. Cardiac allograft vasculopathy after heart transplantation: Is it really ominous?
Lim JY; Jung SH; Kim MS; Park JJ; Yun TJ; Kim JJ; Lee JW
Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27935648
[TBL] [Abstract][Full Text] [Related]
19. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
[TBL] [Abstract][Full Text] [Related]
20. Cardiac allograft vasculopathy and graft failure in pediatric heart transplant recipients after rejection with severe hemodynamic compromise.
Kleinmahon JA; Gralla J; Kirk R; Auerbach SR; Henderson HT; Wallis GA; Ramakrishnan K; Singh RK; Caldwell RL; Savage AJ; Everitt MD
J Heart Lung Transplant; 2019 Mar; 38(3):277-284. PubMed ID: 30638837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
